ABOUT APTUIT - THE PAST and NOW the present as an evotec company
Established in 2004, Aptuit operated as a privately owned pharmaceutical services provider for thirteen years until it became an Evotec company in August 2017.
As a member company of Evotec, Aptuit offers a complete set of integrated drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 4,500 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
To learn more....
The broad range of integrated capabilities includes:
Integrated Chemistry, Manufacturing and Controls
|Integrated CMC overview
|Analytical development and QC
|Drug Product Development and Manufacturing
Integrated Preclinical Development
|Integrated Preclinical Development overview
|Abuse Liability Assessment
INDiGO | Best-in-class candidate selection and IND-enabling solutions
INDiGO and INDiGO-Select are Evotec's integrated drug development solutions to de-risk and accelerate your IND-enabling programs
Aptuit’s offerings also include due diligence and consultancy services.
We operate from Verona (Italy) and Abingdon, Oxfordshire (UK)
If you wish to learn more about Evotec's core competencies and partnered Drug Discovery and Development solutions, you can visit our website and if you prefer to talk to our experts view the contact information below.
Read the privacy statement here
If you wish to speak to our Business Development team, please fill out the contact form below or send a message to email@example.com
For information about career opportunities, please visit our Company career page.